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Abstract 
 
Monte Carlo codes are rapidly spreading among hadron therapy community 
due to their sophisticated nuclear/electromagnetic models which allow an 
improved description of the complex mixed radiation field produced by 
nuclear reactions in therapeutic irradiation.   
In this contribution results obtained with the Monte Carlo code FLUKA are 
presented focusing on the production of secondary fragments in carbon ion 
interaction with water and on CT-based calculations of absorbed and 
biological effective dose for typical clinical situations. The results of the 
simulations are compared with the available experimental data and with the 
predictions of the GSI analytical treatment planning code TRiP.  
 
 
1         Introduction 
The use of ion beams in tumour therapy requires accurate understanding and description of the 
complex process of ion interaction with matter, especially regarding the production of secondary 
particles. In fact, during radiation therapy, secondary neutrons, protons and heavier fragments 
contribute to the dose delivered to the tumour and healthy tissue outside the treated volume. 
Production of light fragments is of special interest since these particles going through the patient body 
broaden the irradiation field and increase the risk of secondary tumours in healthy tissue. In addition, 
the secondary particles leaving the patient body could be exploited for in-vivo verification of the 
treatment delivery simultaneously to the therapeutic irradiation. Furthermore, the biological efficacy 
of the reaction products differs from that of the primary ions and has to be included in biological dose 
calculations for a correct treatment planning. 
Monte Carlo (MC) statistical methods are increasingly considered powerful computational tools for 
accurate calculations of dose deposition in treatment planning, since they are assumed to provide a 
realistic representation of the physical interactions undergone by the primary and the  secondary ions 
which are produced. Among the existing MC codes, FLUKA [1,2] represents a valuable choice thanks 
to: 
 Its precise and reliable physical models for transport and interaction of all the components of 
the expected radiation field; 
 The capability to import the irradiation geometry from CT scans to carefully take into account 
the density and the composition of the irradiated areas [3-5]; 
 The coupling to radiobiological models for the evaluation of biological effects, like cell killing 
[5-7]. 
In this contribution, we present results from a recent benchmark of the FLUKA code against mixed 
field measurements for a 400 MeV/u carbon ion beam on water targets [5,8,9] as well as calculations 
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of physical and biological dose deposition for carbon ion beams in the patient anatomy as given by the 
diagnostic CT (Computed Tomography) scan [5,6]. These latter calculations have been compared with 
the predictions of the GSI analytical treatment planning (TRiP98, TReatment Planning for Particles, 
1998) [10-12].  
 
 
2        Material and Methods 
During therapeutic irradiation nuclear reactions occur between the incident ions and the target tissue. 
These processes need to be correctly taken into account for estimating how the radiation field is 
modified through a decrease of the primary ion yield and a build-up of secondary fragments. In 
particular secondary lower-charge fragments, having longer ranges than primary ions, produce a 
characteristic dose tail beyond the Bragg peak. Their angular and energy spectra also substantially 
differ from that of the primary ions. Light fragments, such as protons and alpha particles, have a broad 
angular distribution while heavier fragments are emitted in a rather narrow cone around the primary 
beam track.  
Promising initial benchmarks of FLUKA against models and experimental data were already reported 
in [13] for therapeutically relevant ion beams. Recently, new experimental measurements have been 
performed at GSI to investigate and characterize the more complex mixed radiation field produced by 
a carbon ion beam at 400 MeV/u (i.e., corresponding to a very deep seated tumor) impinging on water 
targets of various thickness [8,9]. Therefore, these new experimental measurements have been 
simulated with the new development version of the FLUKA code interfaced with the latest version of 
the BME (Boltzmann Master Equation) event generator [14]. 
For calculating biological optimized patient plans Treatment Planning Systems (TPS) for carbon ion 
therapy have to deal with the complexity of the mixed radiation field. Differently from proton therapy 
where typically a constant relative biological effectiveness (RBE) of 1.1 is used, the physical beam 
models of carbon ion TPS in order to correctly estimate their RBE have to take into account the 
secondary fragment yield at each penetration depth in terms of ion species and energy. In clinical 
practice, TPS for hadron therapy are essentially analytical codes based on fast performing pencil-beam 
algorithms and on input physical databases describing the electromagnetic/nuclear interaction of the 
incoming beam in water.  
However, MC codes are being more and more considered valuable computational tools to support 
treatment planning, due to their accurate estimation of the mixed radiation field in arbitrary materials. 
In fact, they allow dose evaluation taking into account the realistic patient stoichiometry and anatomy 
instead of the water-equivalent approach typically exploited by the analytical treatment planning 
algorithms [3-5]. This can be particularly advantageous in the description of the projectile/target 
fragmentation, and in the presence of large density gradients. Finally, MC simulations can provide 
accurate physical databases for TPS [15].   
In order to perform biological effective dose calculations, FLUKA has been interfaced with the Local 
Effect Model (LEM) [16-18] that has been successfully applied within treatment planning in the GSI 
Helmholtzzentrum für Schwerionenforschung pilot project for carbon ion tumour therapy over more 
than 10 years. This model is based on the knowledge of charged particle track structure in combination 
with the response of biological objects to conventional photon radiation. Starting from the LEM 
generated relative biological effectiveness tables we calculated on a particle by particle basis the 
biological response after carbon ion irradiation following the low dose approximation approach [18]. 
This approach has been tested simulating carbon ion pristine Bragg peaks [5] and patient-like 




3        Results and Discussion 
Examples of the results obtained for the benchmarking of FLUKA against experimental data for a 400 
MeV/u carbon ion beam in water are reported in figures 1 to 4 [5,8,9]. Figure 1 depicts the depth-dose 
curve in water, split into the contribution from the primary beam and the secondary fragments [19], 
while the figure 2 shows the simulated contribution of the individual secondary fragments. The tail 
consists mainly of H and He fragments but a not negligible contribution is due to heavier fragments 
such as B (figure 2). Its correct estimation is demanded for a reliable determination of the dose 
delivered to the healthy tissues in the proximity of the treated tumour. 
 
 
Figure 1: Bragg curve as a function of depth in water for a 400 MeV/u carbon beam. The points [8,9] 
and the solid line [19] represent the experimental data and the FLUKA calculations, respectively. The 
dose contribution from primary 12C ions and secondary fragments is also reported. Both the 
experimental data and the MC results are normalized to give the same integral dose between the 
entrance region and the Bragg peak.  
 
 





Figure 3: Angular distributions of the light secondary fragments (H and He) behind a 31.2 cm thick 
water phantom irradiated with a 400 Me/u carbon ion beam. The points [8,9] give the experimental 
data while the histograms depict the FLUKA results [5]. 
 
 
Figure 4: Angular distributions of the heavy secondary fragments (Li, Be and B) behind a 31.2 cm 
thick water phantom irradiated with a 400 MeV/u carbon beam. The points [8,9] give the experimental 
data while the histograms depict the FLUKA results [5]. 
 
Figure 3 and figure 4 show the angular distributions of the secondary products behind a 31.2 cm thick 
water phantom still in 400 MeV/u 12C irradiation. Generally, the width of the angular distribution 
depends on the fragments; He and especially H have broad distributions. With increasing mass, the 
distributions become progressively narrower. At this depth the fragment spectrum is dominated by H 
and He fragments while the amount of boron drops rapidly. The lighter fragments show the broadest 
angular spectra while the heavier ones (Li, Be and B) are emitted in a rather low narrow cone of about 
0° to 5°. The Monte Carlo simulations reproduce all these features except for H where an 
underestimation of its yield is evident in the very forward direction. This discrepancy suggests the 
necessity of further ameliorations both in the nucleus-nucleus event generators and in the transport 
algorithms to cope with the large number of effects to be considered for simulating a thick target 
experiment. Among them, the accurate modelling of the experimental setup could be especially 
important. However, the shown results, in addition to what already presented in [5,13] seem to 
indicate that FLUKA reliably describes the angular distribution of the mixed radiation field. This is an 




Figure 5 represents a comparison between FLUKA calculated dose deposition and the planned 
treatment obtained with TRiP98 [10-12] for a clivus chordoma patient treated at GSI with carbon ion 
beams [6]. The shapes of the calculated dose distributions are found in good agreement except in the 
peripheral low dose region probably due to the fact that MC fully takes into the account multiple 
scattering of primary beam and angular yield of secondary fragments whereas this version of TRiP98 
does not. However, in this specific patient case this simplification of the analytical treatment planning 
system has no clinical impact. By interfacing the LEM model with FLUKA we have additionally 
calculated the biological effective dose distributions. An example of the obtained results is reported on 
the right side of figure 5 for the same patient case depicted on the left side. 
 
 
Figure 5: MC versus TRiP98 calculated distributions of absorbed dose (left side) and biological dose 
(right side) for a clivus chordoma patient. The rainbow colour-bar displays absorbed/biological dose 






4        Conclusions and Outlook 
As a result of the recent efforts made by the FLUKA Collaboration to produce reliable nucleus-
nucleus event generators in the energy range of therapeutic relevance, the FLUKA Monte Carlo code 
now represents a valuable tool for all the ion species selected for the operational and upcoming ion 
treatment facilities in the entire energy range of therapeutic relevance.  
Besides physical dose calculations in standard geometries and directly on the patient CT scan, the 
novel interface with LEM [6,7] allows one  to perform with FLUKA also biological effective dose 
calculations in carbon ion therapy, as actually made with the biological models used by the currently 
available analytical TPS.  
Although the long computing time prevents, at the moment, the use of the FLUKA code both for 
proton and carbon ion calculations in daily clinical routine, Monte Carlo methods can be vey useful 
for deeper investigations of recalculated treatment plans in selected patient cases. Intercomparisons 
between analytical TPS and MC forward recalculations for critical clinical situations in the presence 
of metallic implants and large tissue inhomogeneities are ongoing at the HIT facility. 
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